Skip to main content

Table 4 Descriptive summary of baseline values of various lung function parameters as well as of differences in those variables between baseline values and values obtained 6 weeks respectively 6 months after radiochemotherapy (RT/CHT.); corresponding p-values were calculated by conducting paired t-tests assessing whether those differences deviate statistically significant from zero.

From: Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study

 

Baseline

6 Weeks after RT/CHT vs Baseline

6 Months after RT/CHT vs Baseline

 

Mean

SD

Mean Diff.

SD

p-value

Mean Diff.

SD

p-value

FVC (L)

3.25

0.83

-0.01

0.55

1.00

-0.18

0.45

1.00

FEV1 (L)

2.16

0.70

-0.02

0.32

1.00

-0.14

0.28

0.72

FEV1/VC (%)

63.62

15.38

2.86

17.06

1.00

2.91

14.16

1.00

RV (L)

3.01

0.82

-0.30

0.47

0.16

-0.11

0.71

1.00

TLC (L)

6.25

1.22

-0.33

0.72

0.54

-0.29

0.71

1.00

RV/TLC (%)

47.91

7.76

-2.35

5.85

1.00

-0.42

7.19

1.00

KCO (ml/(min*mmHg*L))

5.74

2.26

-0.34

1.49

1.00

0.08

2.32

1.00

Pao2 (mmHg)

62.89

6.40

2.61

6.24

1.00

0.27

6.53

1.00

Paco2 (mmHg)

39.12

2.71

-2.01

3.97

0.54

-1.47

3.70

1.00